现代消化及介入诊疗
現代消化及介入診療
현대소화급개입진료
MODERN DIGESTION & INTERVENTION
2013年
5期
273-276
,共4页
钟武装%宋卫兵%杨键%肖丽萍%杨明常%刘岗%谢涣琴%蔡敏捷%乐德
鐘武裝%宋衛兵%楊鍵%肖麗萍%楊明常%劉崗%謝渙琴%蔡敏捷%樂德
종무장%송위병%양건%초려평%양명상%류강%사환금%채민첩%악덕
炎症性肠病%细胞间黏附分子-l%D-乳酸%二胺氧化酶
炎癥性腸病%細胞間黏附分子-l%D-乳痠%二胺氧化酶
염증성장병%세포간점부분자-l%D-유산%이알양화매
Inflammatory Bowel Disease (IBD)%Intercellular adhesion molecule-1%Plasma Diamine Oxidase%D-lactate
目的:研究炎症性肠病(Inflammatory Bowel Disease, IBD)患者可溶性血清细胞间黏附分子-l (sICAM-1)、血浆D-乳酸、二胺氧化酶(DAO)、白细胞(WBC)的变化及其临床意义。方法将108例IBD患者和60例健康体检者分为观察组和对照组,对两组分别采用酶联免疫法测定血清sICAM-l,分光光度法检测D-乳酸和DAO水平,常规检查白细胞计数。结果 IBD患者sICAM-1、血浆D-乳酸、DAO、WBC明显高于对照组(P<0.01)。IBD患者sICAM-l与血浆D-乳酸、DAO、WBC水平均显著相关(P<0.01)。治疗前溃疡性结肠炎和克罗恩病两组患者间sICAM-l、DAO、D-乳酸、WBC的水平比较无显著差异性(P>0.05),而治疗后sICAM-l、DAO、D-乳酸水平显著低于治疗前(P<0.01)。结论 sICAM-1,血浆D-乳酸和DAO与病情程度密切相关,sICAM-1可作为IBD患者病情的主要监测指标之一。
目的:研究炎癥性腸病(Inflammatory Bowel Disease, IBD)患者可溶性血清細胞間黏附分子-l (sICAM-1)、血漿D-乳痠、二胺氧化酶(DAO)、白細胞(WBC)的變化及其臨床意義。方法將108例IBD患者和60例健康體檢者分為觀察組和對照組,對兩組分彆採用酶聯免疫法測定血清sICAM-l,分光光度法檢測D-乳痠和DAO水平,常規檢查白細胞計數。結果 IBD患者sICAM-1、血漿D-乳痠、DAO、WBC明顯高于對照組(P<0.01)。IBD患者sICAM-l與血漿D-乳痠、DAO、WBC水平均顯著相關(P<0.01)。治療前潰瘍性結腸炎和剋囉恩病兩組患者間sICAM-l、DAO、D-乳痠、WBC的水平比較無顯著差異性(P>0.05),而治療後sICAM-l、DAO、D-乳痠水平顯著低于治療前(P<0.01)。結論 sICAM-1,血漿D-乳痠和DAO與病情程度密切相關,sICAM-1可作為IBD患者病情的主要鑑測指標之一。
목적:연구염증성장병(Inflammatory Bowel Disease, IBD)환자가용성혈청세포간점부분자-l (sICAM-1)、혈장D-유산、이알양화매(DAO)、백세포(WBC)적변화급기림상의의。방법장108례IBD환자화60례건강체검자분위관찰조화대조조,대량조분별채용매련면역법측정혈청sICAM-l,분광광도법검측D-유산화DAO수평,상규검사백세포계수。결과 IBD환자sICAM-1、혈장D-유산、DAO、WBC명현고우대조조(P<0.01)。IBD환자sICAM-l여혈장D-유산、DAO、WBC수평균현저상관(P<0.01)。치료전궤양성결장염화극라은병량조환자간sICAM-l、DAO、D-유산、WBC적수평비교무현저차이성(P>0.05),이치료후sICAM-l、DAO、D-유산수평현저저우치료전(P<0.01)。결론 sICAM-1,혈장D-유산화DAO여병정정도밀절상관,sICAM-1가작위IBD환자병정적주요감측지표지일。
Objective To explore the change of sICAM-1, plasma diamine oxidase (DAO) and D-lac-tate in IBD patients and its clinical significance. Methods Sixty-eight patients with IBD were employed as experimental group, while 30 healthy people served as control group. The concentration of DAO and D-lactate was measured with spectrophotometric assay and sICAM-1 by ELISA assay. Results The concentration of sICAM-1, DAO and D-lactate in IBD group were significantly higher than those in control group (P<0.01). There were no significant differences among the levels of sICAM-1, DAO and D-lactate between ulcerative colitis and Crohn′s disease patients (P>0.05).The levels of sICAM-1, DAO and D-lactate in IBD patients were positively correlated with each other (P<0.01). After therapy, The levels of sICAM-1, DAO and D-lac-tate were decreased significantly in IBD patients (P<0.01) after treatment. Conclusion The concentration changes of plasma sICAM-1, DAO and D-lactate in IBD patients are closely related to their clinical symp-toms, which could be a potential laboratory index for IBD patients.